Cough swabs should not be used to isolate non-tuberculous mycobacteria in children with cystic fibrosis Non-tuberculous mycobacterium (NTM) account for 13% of cystic fibrosis (CF)-related respiratory infections and present a major therapeutic challenge.
1
There is increasing evidence to suggest an adverse prognostic significance of NTM, particularly for Mycobacterium abscessus. A recent large retrospective study of 1216 patients with CF found that growths of NTM were associated with progressive deterioration in lung function. 2 Therefore, accurate microbiological diagnosis of NTM is important.
In our centre, NTM cultures are collected routinely at annual assessment, on admission for a chest exacerbation, and when assessing patients for a progressive or unexplained respiratory deterioration (http://www.rbht. nhs.uk/childrencf). This is problematic in patients who are unable to produce sputum, particularly the very young in whom only cough swabs are easily and routinely available. We always send bronchoalveolar lavage (BAL) fluid for NTM culture if a child with CF is undergoing a bronchoscopy, but this procedure is not carried out routinely. To our knowledge, there have been no reports on the usefulness of cough swabs for isolating NTM. This letter reports a retrospective analysis of the NTM culture results of 331 patients in a large paediatric specialist CF centre. Results were examined over a 3-year period (2009-2011 inclusive) to identify all positive NTM results. Only those cases where both cough swabs and sputum or BAL samples were taken within close succession were included.
There were a total of 16 cases in whom NTM was isolated, but in 10 cases, NTM was isolated on BAL or sputum, and cough swabs were not sent. In the six cases with comparable samples, none of the cultured cough swabs yielded NTM, despite positive sputum or BAL cultures, both before and after cough swabs were taken (see table 1 ). This suggests that cough swabs should not be relied on for diagnosing NTM infection. Therefore, when cultures for NTM are indicated, particularly in patients with progressive disease, alternative specimens, such as BAL or induced sputum, should be sought in non-expectorating children.
Bushra Ahmed, 1 Ian M Balfour-Lynn, 1 Khalid Alshafi
